On 7 April 2026, the Health and Safety Executive launched a consultation seeking views on expanding the requirements in the Reporting of Injuries, Diseases and Dangerous Occurrences Regulations 2013, including reintroducing reports of pneumoconiosis, which includes silicosis. The consultation remains live until 30 June.

The UK Health Security Agency (UKHSA) plays a key role in addressing group B streptococcus (GBS) infection both through routine service activities and innovative research.

The UKHSA does not believe that there is a rationale at present for GBS being added to the Health Protection Notification Regulations. There are no immediate and specific public health actions required to be taken in response to a case being diagnosed. Whilst periods of enhanced surveillance suggest routine surveillance may be underestimating numbers of infections, this has not been audited to identify the source and reason for discrepancies between different sources of reports during these periods. Given the largely automated nature of laboratory surveillance, making GBS notifiable would not necessarily address any deficits in reporting.

The list of notifiable disease is kept under review by the Department with the UKHSA involvement. Further information is available at the following link:

https://www.gov.uk/government/consultations/health-protection-notification-regulations-2010-proposed-amendments/outcome/government-response-to-the-health-protection-notification-regulations-2010-proposed-amendments

The UK Health Security Agency (UKHSA) does not recommend adding Group B Streptococcus as a notifiable disease. Existing national surveillance effectively captures Group B Streptococcus infections, monitors trends, and informs antibiotic prescribing policy. The UKHSA has assessed that mandatory notification for Group B Streptococcus would provide no additional public health benefit beyond this.

Candidozyma, formerly Candida, auris is an emerging multi-drug resistant fungal pathogen. Candidozyma auris is becoming more widespread globally, can result in serious infections in vulnerable individuals, and has been associated with outbreaks in healthcare settings that have resulted in substantial service disruption. The addition of candidozyma auris to the Health Protection (Notification) Regulations as a notifiable organism under Schedule 2 enables the UK Health Security Agency to more closely monitor this pathogen and inform public health action to limit its spread within the United Kingdom.

The Health Protection (Notification) (Amendment) Regulations 2025 Impact Assessment, a copy of which is attached, highlights that testing for candidozyma auris would be conducted within National Health Service and private laboratories. The burden on laboratories for additional testing is likely to be low, as testing is straightforward.

Yemen remains one of the world's worst humanitarian crises including with 4.8 million Internally Displaced Persons (IDPs). The UK provided £144 million in humanitarian aid in financial year 2024/2025 and is currently the largest donor to the Yemen Humanitarian Needs and Response Plan for this financial year.

Both of the UK's humanitarian programmes support the most vulnerable in Yemen, including IDPs. The UK's Women and Children programme provides primary health care and nutrition, water hygiene and sanitation, and sexual and reproductive health services. In 2025, the programme supported 534 health facilities, providing basic medicines, health workers and community outreach to over one million people, including IDPs. The UK's Food Safety and Security Nets programme has supported more than 26,000 IDPs this year. The programme supports vulnerable communities with cash for food and living expenses, delivers "shock responsive" funding to all those impacted by flooding, and provides direct support to Women's Rights Organisations working with IDPs. The programme has supported more than 88,000 people with Gender Based Violence (GBV) and child protection services, essential given the increased exposure to GBV that IDPs face.

We are working with international partners to respond to these growing needs. The UK and Saudi Arabia have worked together on a $10 million joint programme on cholera in Yemen. Working through the United Nations International Children's Fund (UNICEF) and the World Health Organization (WHO), this joint programme tackled cholera in the most high-risk and affected communities, including IDP communities.

Formal notification and negotiation of proposed resolutions at the World Health Organization (WHO) typically begin in the autumn, including any potential resolution on making traumatic brain injury a notifiable and chronic condition. The United Kingdom gives due consideration to all proposed WHO resolutions and will engage in all resolution negotiations ahead of any adoption at the World Health Assembly, which takes place in May each year. All resolutions to be considered by the World Health Assembly would also be subject to the WHO's budget allocation process.

The UK is committed to addressing traumatic brain injury and we intend to develop an Acquired Brain Injury (ABI) Action or Delivery Plan, with input from NHS England and other Government departments, to be published in the autumn of this year. The forthcoming 10-Year Health Plan will provide the overarching plan for the future of the National Health Service, and a subsequent ABI Plan would then focus on specific actions and deliverables for ABI against the backdrop of the 10-Year Health Plan. This will ensure a coherent, targeted approach. The new ABI Action Plan will be concise, action-oriented, and accountable, in order to drive real change for people with ABI.

My Department holds information on the release of Pheasants and Red-legged partridges on and within a 500m buffer of Special Areas of Conservation (SACs) and Special Protection Areas (SPAs) in England for the last four years for SACs and two years for SPAs.

In addition, the outcome of veterinary investigations conducted by the Animal and Plant Health Agency (APHA) at all sites where highly pathogenic avian influenza (HPAI) has been confirmed in poultry or other captive birds including any cases in kept gamebirds are published on gov.uk in APHA’s outbreak epidemiology reports. These reports include information on potential pathways to infection at the infected premises.

Once gamebirds have been released, they are classed as wild birds for avian influenza rules. Reports of mortality in release gamebirds are investigated through APHA’s wild bird surveillance programme. Details of findings of HPAI in wild birds are published on gov.uk and are available to view and interrogate via APHA’s interactive wild bird surveillance map and dashboard.

Over the last five years highly pathogenic avian influenza (HPAI) has been confirmed at seven premises (five in England, one in Scotland and one in Wales) where commercial gamebirds have been kept, out of a total of 411 premises were HPAI has been confirmed in poultry or other captive birds. Under avian influenza rules gamebird covers any pheasant, partridge, ptarmigan, grouse or moor game, black (or heath) game and ducks bred for shooting.

The Animal and Plant Health Agency (APHA) holds records of how many poultry or other captive birds including kept gamebirds are culled for disease control purposes by Government. In addition, the outcome of veterinary investigations conducted by APHA at all sites where HPAI has been confirmed in kept birds including any cases in kept gamebirds are published on gov.uk in APHA’s outbreak epidemiology reports. These reports include information on the number and type of birds present at infected premises.

Over the last five years highly pathogenic avian influenza (HPAI) has been confirmed at seven premises (five in England, one in Scotland and one in Wales) where commercial gamebirds have been kept, out of a total of 411 premises were HPAI has been confirmed in poultry or other captive birds. Under avian influenza rules gamebird covers any pheasant, partridge, ptarmigan, grouse or moor game, black (or heath) game and ducks bred for shooting.

The Animal and Plant Health Agency (APHA) holds records of how many poultry or other captive birds including kept gamebirds are culled for disease control purposes by Government. In addition, the outcome of veterinary investigations conducted by APHA at all sites where HPAI has been confirmed in kept birds including any cases in kept gamebirds are published on gov.uk in APHA’s outbreak epidemiology reports. These reports include information on the number and type of birds present at infected premises.

Patient confidentiality is of vital importance to retain patients’ trust in sexual health services, and to encourage access to advice, testing, diagnosis, and treatment of sexually transmitted infections (STIs).

A public consultation seeking views on proposals to amend the Health Protection (Notification) Regulations 2010 was held between 12 July and 15 November 2023. This included the proposal to add specific STIs to schedule 2 of the regulations to strengthen surveillance. The consultation asked for views on the consequences of this change, including whether it could negatively impact public trust in the confidentiality of sexual health services and data and risk creating a barrier to accessing sexual services.

The Department and the UK Health Security Agency are considering the responses to the consultation and are grateful for stakeholders’ continued engagement on this topic.

Patient confidentiality is of vital importance in sexual health to retain patients’ trust in services, and to encourage access to advice, testing, diagnosis, and treatment of sexually transmitted infections. A public consultation seeking views on proposals to amend the Health Protection (Notification) Regulations (HPNR) 2010 was held between 12 July and 15 November 2023. This included a commitment that any decision on adding specific sexually transmitted infections to schedule 2 of the regulations would be shaped by consultation responses and engagement with stakeholders.

The Department and the UK Health Security Agency are considering the responses to the consultation and are grateful for stakeholders’ continued engagement on this topic.

The Reporting of Injuries, Diseases and Dangerous Occurrences Regulations 2013 (RIDDOR) are made under the Health and Safety at Work etc Act 1974 and apply to all sectors and workplaces in Great Britain.

The 2013 regulations clarified and simplified the list of reportable ill-health conditions (occupational diseases), as a result of a recommendation made by Professor Löfstedt in his report “Reclaiming health and safety for all: An independent review of health and safety (legislation,” published in 2011.

Under the regulations, HSE is required to review RIDDOR every five years. A review has recently been completed and its recommendations published. One of these recommendations was to review the list of reportable occupational diseases. HSE is currently considering how best to take this forward.

Following a review of the Health Protection (Notification) Regulations 2010 by the Department and the UK Health Security Agency (UKHSA), the Government published a public consultation between 12 July and 15 November 2023, seeking views on proposed amendments to the regulations.

Adding Group B Streptococcal Infection to schedule 1 of the regulations was not included in the consultation proposals, but a small number of respondents suggested it could be suitable for inclusion.

A summary of responses to the consultation has been published. The Department and UKHSA are considering the consultation responses, and confirmation of any changes to the regulations will be published in due course.

In November 2023, the Health and Safety Executive (HSE) published its annual report entitled “Silicosis and coal workers’ pneumoconiosis statistics in Great Britain, 2023”.

In October 2023 HSE published the second Post Implementation Review (PIR) of RIDDOR, with a view to expanding it to include areas where HSE regulatory intervention can add value. Of the five recommendations, work is already underway on the first two, regarding guidance and online reporting.

HSE will start the process of reviewing the remaining recommendations, including the inclusion of Pneumoconiosis (e.g., silicosis), within the next business year.

The Secretary of State for Business and Trade maintains regular dialogue with the Secretary of State for Environment, Food and Rural Affairs on a wide range of issues relating to agriculture and trade. The government will continue to prioritise trade facilitation in our free trade agreements to benefit UK exports.